ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase 3
Completed
Conditions
First Posted Date
2006-06-01
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
586
Registration Number
NCT00332436

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
First Posted Date
2006-06-01
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
73
Registration Number
NCT00332345

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase 3
Completed
Conditions
First Posted Date
2006-06-01
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
573
Registration Number
NCT00332384

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2006-05-15
Last Posted Date
2011-06-02
Lead Sponsor
Allergan
Target Recruit Count
150
Registration Number
NCT00325715

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
First Posted Date
2006-03-09
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
561
Registration Number
NCT00300443

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

First Posted Date
2006-02-01
Last Posted Date
2012-12-17
Lead Sponsor
Allergan
Target Recruit Count
380
Registration Number
NCT00284518

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Phase 2
Completed
Conditions
First Posted Date
2005-11-07
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
400
Registration Number
NCT00249782
Locations
🇺🇸

University Clinical Research, Inc., Pembroke Pines, Florida, United States

🇺🇸

Paddington Testing Co., Inc., Philadelphia, Pennsylvania, United States

🇺🇸

Academic Dermatology Associates, Albuquerque, New Mexico, United States

and more 22 locations

A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop

Phase 2
Completed
Conditions
First Posted Date
2005-10-25
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
286
Registration Number
NCT00243711

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Phase 4
Completed
Conditions
First Posted Date
2005-10-24
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
64
Registration Number
NCT00243542
Locations
🇺🇸

Okatie Research Center, LLC, Beaufort, South Carolina, United States

🇺🇸

Dermatology Associates, PC at the Washington Hospital Center, Washington, District of Columbia, United States

🇺🇸

Dermatology Associates of Knoxville, Knoxville, Tennessee, United States

and more 26 locations
© Copyright 2024. All Rights Reserved by MedPath